0 CHECKOUT

Urinary Incontinence - Pipeline Review, H1 2015

  • ID: 3106240
  • January 2015
  • 66 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Allergan, Inc.
  • Astellas Pharma Inc.
  • Beech Tree Labs, Inc.
  • Cook MyoSite Incorporated
  • Evotec AG
  • Recordati S.p.A.
  • MORE

Urinary Incontinence - Pipeline Review, H1 2015

Summary

This, ‘Urinary Incontinence - Pipeline Review, H1 2015’, provides an overview of the Urinary Incontinence’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Urinary Incontinence, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Urinary Incontinence and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan, Inc.
  • Astellas Pharma Inc.
  • Beech Tree Labs, Inc.
  • Cook MyoSite Incorporated
  • Evotec AG
  • Recordati S.p.A.
  • MORE

List of Tables
List of Figures
Introduction
REPORT COVERAGE
Urinary Incontinence Overview
Therapeutics Development
Pipeline Products for Urinary Incontinence - Overview
Pipeline Products for Urinary Incontinence - Comparative Analysis
Urinary Incontinence - Therapeutics under Development by Companies
Urinary Incontinence - Therapeutics under Investigation by Universities/Institutes
Urinary Incontinence - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Urinary Incontinence - Products under Development by Companies
Urinary Incontinence - Products under Investigation by Universities/Institutes
Urinary Incontinence - Companies Involved in Therapeutics Development
Allergan, Inc.
Astellas Pharma Inc.
Beech Tree Labs, Inc.
Cook MyoSite Incorporated
Evotec AG
FemmePharma Global Healthcare, Inc.
Innovacell Biotechnologie AG
Recordati S.p.A.
TheraVida, Inc.
Urinary Incontinence - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
(mirabegron + solifenacin succinate) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
(tolterodine + pilocarpine) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BTL-ui - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cell Therapy for Urinary Incontinence - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ICES-13 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
oxybutynin hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Prof-003 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
REC-1819 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
senrebotase - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Antagonize P2X3 and P2X2/3 for Inflammatory Pain, Neuropathic Pain and Urinary Incontinence - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for CAD, Urinary Incontinence and Fecal Incontinence - Drug Profile
Product Description
Mechanism of Action
R&D Progress
THVD-202 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Urinary Incontinence - Recent Pipeline Updates
Urinary Incontinence - Dormant Projects
Urinary Incontinence - Discontinued Products
Urinary Incontinence - Product Development Milestones
Featured News & Press Releases
Jul 03, 2013: Impax Laboratories Confirms Patent Challenge Relating to Generic TOVIAZ 4 mg and 8 mg
Jan 03, 2013: TheraVida Announces Positive Top-line Phase II Results For Tolenix In Patients With Overactive Bladder And Urge Urinary Incontinence
Nov 06, 2012: Beech Tree Labs Completes Phase IIa Urinary Incontinence Clinical Trial Using UISH001
Mar 15, 2012: Innovacell To Present Phase IIb Trial Results Of ICES13 At MedTech Investing Europe Conference
Dec 05, 2011: Pfizer’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Elderly Patients
Nov 08, 2011: Pfizer Announces Positive Top-Line Primary Endpoint Results Of Toviaz In Overactive Bladder Including Nocturnal Urinary Urgency
Aug 30, 2011: Innovacell passes a further milestone
May 16, 2011: TheraVida Initiates Phase II Trial Of THVD-201 For Overactive Bladder And Urinary Incontinence
Apr 13, 2011: Beech Tree Labs Initiates Urinary Incontinence Trial
Mar 22, 2011: TheraVida Announces Positive Results From Phase I Trial Of THVD-201
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Urinary Incontinence, H1 2015
Number of Products under Development for Urinary Incontinence - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Investigation by Universities/Institutes, H1 2015
Urinary Incontinence - Pipeline by Allergan, Inc., H1 2015
Urinary Incontinence - Pipeline by Astellas Pharma Inc., H1 2015
Urinary Incontinence - Pipeline by Beech Tree Labs, Inc., H1 2015
Urinary Incontinence - Pipeline by Cook MyoSite Incorporated, H1 2015
Urinary Incontinence - Pipeline by Evotec AG, H1 2015
Urinary Incontinence - Pipeline by FemmePharma Global Healthcare, Inc., H1 2015
Urinary Incontinence - Pipeline by Innovacell Biotechnologie AG, H1 2015
Urinary Incontinence - Pipeline by Recordati S.p.A., H1 2015
Urinary Incontinence - Pipeline by TheraVida, Inc., H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Urinary Incontinence Therapeutics - Recent Pipeline Updates, H1 2015
Urinary Incontinence - Dormant Projects, H1 2015
Urinary Incontinence - Dormant Projects (Contd..1), H1 2015
Urinary Incontinence - Dormant Projects (Contd..2), H1 2015
Urinary Incontinence - Discontinued Products, H1 2015
Urinary Incontinence - Discontinued Products (Contd..1), H1 2015

List of Figures
Number of Products under Development for Urinary Incontinence, H1 2015
Number of Products under Development for Urinary Incontinence - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

Allergan, Inc.
Astellas Pharma Inc.
Beech Tree Labs, Inc.
Cook MyoSite Incorporated
Evotec AG
FemmePharma Global Healthcare, Inc.
Innovacell Biotechnologie AG
Recordati S.p.A.
TheraVida, Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S